Viewing Study NCT04502394


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2025-12-27 @ 11:50 PM
Study NCT ID: NCT04502394
Status: UNKNOWN
Last Update Posted: 2022-08-04
First Post: 2020-07-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
Sponsor: Kartos Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module